What are the contraindications for vasopressin use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Vasopressin Use

Vasopressin is absolutely contraindicated in patients with known allergy or hypersensitivity to 8-L-arginine vasopressin or chlorobutanol, and terlipressin (a vasopressin analog) is contraindicated in patients with hypoxemia, ongoing coronary ischemia, peripheral ischemia, or mesenteric ischemia. 1, 2

Absolute Contraindications

FDA-Labeled Contraindications

  • Known allergy or hypersensitivity to 8-L-arginine vasopressin 1
  • Chlorobutanol allergy (preservative in vasopressin formulations) 1

Terlipressin-Specific Contraindications (Vasopressin Analog)

  • Hypoxemia or worsening respiratory symptoms 2, 3
  • Ongoing coronary ischemia 2, 3
  • Ongoing peripheral ischemia 2, 3
  • Ongoing mesenteric ischemia 2, 3

Relative Contraindications and High-Risk Situations

Cardiovascular Concerns

  • Hypovolemia: Norepinephrine is relatively contraindicated in hypovolemic patients, and vasopressin shares similar concerns as it can worsen cardiac output without adequate preload 2
  • Decompensated heart failure: Beta blockers are contraindicated in acute pulmonary edema, and vasopressin can worsen cardiac function 2, 1
  • Severe cardiac dysfunction: Vasopressin can decrease cardiac output and cause bradycardia 1

Critical Illness Severity

  • Acute-on-chronic liver failure grade 3: Terlipressin should be used with extreme caution as benefits may not outweigh risks 2, 3
  • Serum creatinine >5 mg/dL: In hepatorenal syndrome, terlipressin benefits may not outweigh risks at this severity 2, 3
  • Model for End-stage Liver Disease score ≥35: Benefits questionable in patients listed for transplantation 2, 3

Dosing Restrictions

  • High-dose vasopressin (>0.03-0.04 units/min): Should be reserved only for salvage therapy when other vasopressors have failed 2, 4
  • Single initial vasopressor use: Vasopressin should NOT be used as the sole initial vasopressor in septic shock; norepinephrine is first-line 2, 4
  • Doses >0.04 units/min: May lead to cardiac arrest 5

Clinical Context-Specific Contraindications

Pulmonary Arterial Hypertension

  • In critically ill PAH patients, vasopressin should be used cautiously and only at replacement doses (typically for vasopressin-deficient states like sepsis or liver disease) to avoid worsening right ventricular afterload 2
  • The priority is maintaining systemic vascular resistance > pulmonary vascular resistance 2

Pregnancy

  • Vasopressin may induce uterine contractions 1

Important Warnings and Monitoring Requirements

Adverse Effects Requiring Vigilance

  • Ischemic complications: Coronary, mesenteric, skin, and digital ischemia are documented risks 1, 5
  • Cardiac effects: Decreased cardiac output, bradycardia, and tachyarrhythmias 1
  • Hyponatremia: Common adverse effect requiring monitoring 1
  • Reversible diabetes insipidus: Can occur with vasopressin use 1

Critical Pitfalls to Avoid

  • Never use vasopressin for variceal hemorrhage: The American Gastroenterological Association explicitly states vasopressin is no longer advised for variceal bleeding due to high cardiovascular risk; octreotide is the preferred agent 2, 6, 4
  • Duration limitation: When used for variceal bleeding historically, vasopressin was limited to 24 hours maximum due to severe cardiovascular side effects 6
  • Extravasation risk: Can cause tissue necrosis; central line administration is strongly preferred 2

Drug Interactions Requiring Caution

  • Additive pressor effects with catecholamines 1
  • Indomethacin may prolong vasopressin effects 1
  • Ganglionic blockers or drugs causing SIADH may increase pressor response 1
  • Drugs causing diabetes insipidus may decrease pressor response 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Terlipressin Administration for Hepatorenal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vasopressin Medications in Vasodilatory Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vasopressin for Bleeding Management in Hepatectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.